High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C

doi:10.3748/wjg.v12.i4.556

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2659)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

276

HTML

1984

Figures (1-2)

221

Tables (1-2)

178

Sum=2659

Jan 28, 2006 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jan 28, 2006; 12(4): 556-560
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.556

Full Size Figure Download Figure

Figure 1 Effectiveness of IFN and serum leptin level in subjects with a low viremia level. NR: Non-responder group for IFN therapy; SR: Sustained responder group. ^aP < 0.05, NR vs SR. Mann-Whitney U-test.

Citation: Eguchi Y, Mizuta T, Yasutake T, Hisatomi A, Iwakiri R, Ozaki I, Fujimoto K. High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C. World J Gastroenterol 2006; 12(4): 556-560
URL: https://www.wjgnet.com/1007-9327/full/v12/i4/556.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i4.556